NO874704D0 - Minaktivin fremstilt ved rekombinant dna-teknikk. - Google Patents

Minaktivin fremstilt ved rekombinant dna-teknikk.

Info

Publication number
NO874704D0
NO874704D0 NO1987874704A NO874704A NO874704D0 NO 874704 D0 NO874704 D0 NO 874704D0 NO 1987874704 A NO1987874704 A NO 1987874704A NO 874704 A NO874704 A NO 874704A NO 874704 D0 NO874704 D0 NO 874704D0
Authority
NO
Norway
Prior art keywords
minactivin
recombinant dna
dna technology
manufactured
purification
Prior art date
Application number
NO1987874704A
Other languages
English (en)
Other versions
NO178504B (no
NO178504C (no
NO874704L (no
Inventor
Toni Marie Antalis
Michael Thomas Barnes
Michelle Alison Clarke
Peter Leonard Devine
Neil Howard Goss
Philip Ralph Lehrbach
Original Assignee
Biotech Australia Pty Ltd
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Univ Australian filed Critical Biotech Australia Pty Ltd
Publication of NO874704L publication Critical patent/NO874704L/no
Publication of NO874704D0 publication Critical patent/NO874704D0/no
Priority to NO952506A priority Critical patent/NO952506D0/no
Publication of NO178504B publication Critical patent/NO178504B/no
Publication of NO178504C publication Critical patent/NO178504C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8132Plasminogen activator inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811Serine protease (E.C. 3.4.21) inhibitors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972Plasminogen activators
    • G01N2333/9723Urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
NO874704A 1986-03-13 1987-11-11 Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat NO178504C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO952506A NO952506D0 (no) 1986-03-13 1995-06-22 Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPH501786 1986-03-13
AUPH603386 1986-05-22
AUPH810086 1986-09-18
AUPH910486 1986-11-21
PCT/AU1987/000068 WO1987005628A1 (en) 1986-03-13 1987-03-13 Minactivin produced by recombinant dna technology

Publications (4)

Publication Number Publication Date
NO874704L NO874704L (no) 1987-11-11
NO874704D0 true NO874704D0 (no) 1987-11-11
NO178504B NO178504B (no) 1996-01-02
NO178504C NO178504C (no) 1996-04-10

Family

ID=27424177

Family Applications (1)

Application Number Title Priority Date Filing Date
NO874704A NO178504C (no) 1986-03-13 1987-11-11 Fr.måte for fr.stilling av minaktivin,DNA-molekyl,gen,vert,prober,preparat som omfatter prober,reagens for lokalisering og defini. av grenser for tumor i histologiske pröver,samt anvendelse av DNA-molekyl,minaktivin og preparat

Country Status (13)

Country Link
US (1) US5426044A (no)
EP (1) EP0238275B1 (no)
JP (2) JP2589996B2 (no)
KR (1) KR960001820B1 (no)
CN (2) CN1032019C (no)
AT (1) ATE132192T1 (no)
CA (1) CA1338381C (no)
DE (1) DE3751646T2 (no)
DK (2) DK172400B1 (no)
IL (1) IL81879A (no)
NO (1) NO178504C (no)
NZ (1) NZ219608A (no)
WO (1) WO1987005628A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
US5298400A (en) * 1989-09-05 1994-03-29 Biotechnology Australia Pty. Ltd. Polynucleotide constructs for secreted glycosylated plasminogen activator inhibitor-2 (PAI-2)
ES2106772T3 (es) * 1989-12-20 1997-11-16 Biotech Australia Pty Ltd Variantes de pai-2.
GB9026737D0 (en) * 1990-12-08 1991-01-30 Delta Biotechnology Ltd Cancer treatment
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
CN102586187A (zh) * 2012-02-23 2012-07-18 深圳市中美康士生物科技有限公司 一种中性粒细胞体外保存方法及培养基

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
DE3587711T2 (de) * 1984-08-13 1994-04-28 Biotech Australia Pty Ltd Minaktivin.
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation

Also Published As

Publication number Publication date
JPH08112094A (ja) 1996-05-07
DE3751646T2 (de) 1996-10-17
NZ219608A (en) 1991-05-28
KR960001820B1 (ko) 1996-02-05
NO178504B (no) 1996-01-02
EP0238275B1 (en) 1995-12-27
EP0238275A3 (en) 1989-05-10
CN1100957A (zh) 1995-04-05
DE3751646D1 (de) 1996-02-08
IL81879A (en) 1994-07-31
NO178504C (no) 1996-04-10
DK172400B1 (da) 1998-05-18
US5426044A (en) 1995-06-20
JP2589996B2 (ja) 1997-03-12
CN87102725A (zh) 1987-11-11
ATE132192T1 (de) 1996-01-15
NO874704L (no) 1987-11-11
KR880701073A (ko) 1988-07-25
WO1987005628A1 (en) 1987-09-24
DK595187A (da) 1988-07-21
JPS63503354A (ja) 1988-12-08
JP2660681B2 (ja) 1997-10-08
CN1032019C (zh) 1996-06-12
DK27097A (da) 1997-03-13
DK595187D0 (da) 1987-11-13
CA1338381C (en) 1996-06-11
EP0238275A2 (en) 1987-09-23

Similar Documents

Publication Publication Date Title
FI100056B (fi) Ihmisproapolipoproteiinin A-I ilmaiseminen
RU95115239A (ru) Аналог эритропоэтина
FI953658A0 (fi) Stabiileja bakterisidisia/läpäisevyyttä parantavia proteiinituotteita ja näitä sisältäviä farmaseuttisia koostumuksia
DE3650645D1 (de) Antigene Proteine und diese enthaltende Impfstoffe zur Verhütung von Kokzidiose
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE91722T1 (de) Pferde-gamma-interferon.
ATE121776T1 (de) Expression des biologisch aktiven faktors xiii.
ATE338113T1 (de) Transferrin-rezeptor gene von haemophilus
DE69737766D1 (de) Zusammensetzungen von stammzellfaktor (scf)-analogen und auf diese bezogene verfahren
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
DE59108947D1 (de) Neues menschliches, rekombinantes interferon gamma
NO930428L (no) Proteinstrukturen til plantetoksingelonin
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
ES2124694T3 (es) Clonacion de la n-metil-hidantoinasa.
DE602004019556D1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
DK210288A (da) Overproduktion af exocelllulaere proteiner
TH5997EX (th) การสร้างโปรอโปดิโปรโปรตีน a-i ของคนโดยการแสดงออกของรหัสพันธุกรรม

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2002